Monday, 19 March 2018

Prevalence and economic burden of medication errors in the NHS in England: Rapid evidence synthesis and economic analysis of the prevalence and burden of medication error in the UK

Prevalence and economic burden of medication errors in the NHS in England: Rapid evidence synthesis and economic analysis of the prevalence and burden of medication error in the UK

University of Sheffield Policy Research Unit in Economic Evaluation of Health & Care Interventions, March 2018.
Report that estimates approximately 66 million potentially clinically significant errors occur per year, 71.0% of these in primary care. This is where most medicines in the NHS are prescribed and dispensed. Prescribing in primary care accounts for 33.9% of all potentially clinically significant errors. It estimates NHS costs of definitely avoidable Adverse Drug Reactions as £98.5 million per year, consuming 181,626 beddays, causing 712 deaths, and contributing to 1,708 deaths. Lancashire Care Library and Information Service

No comments:

Post a Comment